Clin2
NCT06955559Possibly a fitNot yet recruiting

Magnesium sulfate for childhood asthma and bronchiolitis

Asthma in Children

Treatments studied

Part of Lungs & breathing clinical trials.

This study tests if giving magnesium sulfate (a mineral supplement) helps children with asthma or bronchiolitis breathe better. It is for children aged 1 month to under 18 years who have these conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
60 people
Ages
1 month to 18 years
Study type
Interventional

Who can take part

  • Your child must be between 1 month and under 18 years old.
  • Your child must have been diagnosed with bronchial asthma or acute bronchiolitis.
  • Your child must not have congenital heart disease (a heart problem present from birth).
  • Your child must not be under 1 month old or 18 years or older.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06137040Recruiting· Early Phase 1
Early IV Magnesium for Moderate Asthma in Children

This trial tests whether giving magnesium sulfate through an IV early in the emergency room helps children aged 5–17 who are having a moderate asthma attack. It aims to improve breathing and reduce the need for hospital stays.

Oklahoma City, Oklahoma
NCT05043116Recruiting· Phase 2
Vitamin D for preventing asthma-like flare-ups in young children

This study tests whether a high-dose vitamin D supplement can help preschool children have fewer acute asthma-like symptoms (coughing, wheezing, or trouble breathing) that require hospital care. It may help by supporting the immune and airway system, but you can only join if the child meets several safety and treatment criteria.

Gentofte Municipality, Gentofte
NCT06785272Recruiting· Phase 3
Magnesium for children with asthma in the ER

This trial tests if giving magnesium sulfate through an IV helps children with moderate to severe asthma attacks in the emergency department. If your child is between 2 and 17 years old and still has trouble breathing after three puffs of standard asthma medicine, this study may be an option.

Calgary, Alberta
NCT07795970Not yet recruiting
High-dose magnesium infusion for severe asthma in the emergency room

This trial tests whether giving a higher dose of magnesium (given as an IV drip) works better than the standard dose for treating a severe asthma attack in the emergency room. It aims to see if the higher dose helps you breathe easier sooner.

NCT06564376Not yet recruiting
Magnesium sulfate to reduce complications in pediatric heart surgery

This trial tests whether giving magnesium sulfate during heart surgery can help reduce complications for children who need a heart-lung machine. It might help your child recover better after surgery.

Morgantown, West Virginia
NCT07835529Not yet recruiting
Magnesium treatment for newborns with birth asphyxia

This trial tests whether giving magnesium sulphate to newborns with birth asphyxia (lack of oxygen at birth) can help them recover faster and shorten their hospital stay.

Hear when a new Asthma in Children trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.